CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 176 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $40,540,000 | +31.6% | 912,651 | +6.8% | 0.01% | +20.0% |
| Q3 2016 | $30,805,000 | +172.8% | 854,514 | +3.8% | 0.01% | +150.0% |
| Q2 2016 | $11,292,000 | -28.7% | 823,036 | -0.2% | 0.00% | -33.3% |
| Q1 2016 | $15,842,000 | -41.3% | 825,085 | +7.1% | 0.00% | -25.0% |
| Q4 2015 | $26,971,000 | -61.2% | 770,609 | +1.9% | 0.00% | -66.7% |
| Q3 2015 | $69,575,000 | +14.6% | 756,580 | +9.5% | 0.01% | +20.0% |
| Q2 2015 | $60,708,000 | +13.6% | 690,801 | -4.0% | 0.01% | +25.0% |
| Q1 2015 | $53,418,000 | +33.3% | 719,622 | +0.5% | 0.01% | +33.3% |
| Q4 2014 | $40,080,000 | +18.4% | 715,720 | -4.1% | 0.01% | 0.0% |
| Q3 2014 | $33,862,000 | +6.9% | 746,516 | -2.4% | 0.01% | +20.0% |
| Q2 2014 | $31,668,000 | -51.6% | 764,733 | -19.0% | 0.01% | -54.5% |
| Q1 2014 | $65,389,000 | +68.6% | 943,970 | +46.7% | 0.01% | +57.1% |
| Q4 2013 | $38,781,000 | +51.1% | 643,462 | +52.5% | 0.01% | +40.0% |
| Q3 2013 | $25,658,000 | +43.9% | 422,004 | +58.6% | 0.01% | +25.0% |
| Q2 2013 | $17,826,000 | – | 266,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |